List of Tables

Table 1. Generic Anti-cancer Injectables Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Generic Anti-cancer Injectables Market Restraints

Table 3. Generic Anti-cancer Injectables Market Trends

Table 4. Generic Anti-cancer Injectables Industry Policy

Table 5. Global Generic Anti-cancer Injectables Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Generic Anti-cancer Injectables Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Generic Anti-cancer Injectables Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Generic Anti-cancer Injectables Mergers & Acquisitions, Expansion Plans

Table 9. Global Generic Anti-cancer Injectables Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Generic Anti-cancer Injectables Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Generic Anti-cancer Injectables Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Generic Anti-cancer Injectables Upstream (Raw Materials)

Table 14. Global Generic Anti-cancer Injectables Typical Customers

Table 15. Generic Anti-cancer Injectables Typical Distributors

Table 16. by Type, Global Generic Anti-cancer Injectables Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Generic Anti-cancer Injectables Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Generic Anti-cancer Injectables Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Generic Anti-cancer Injectables Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Generic Anti-cancer Injectables Consumption Value Market Share, 2020-2031

Table 23. Teva Company Information, Head Office, Market Area, and Industry Position

Table 24. Teva Company Profile and Main Business

Table 25. Teva Generic Anti-cancer Injectables Models, Specifications, and Application

Table 26. Teva Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Teva Recent Developments

Table 28. Viatris Company Information, Head Office, Market Area, and Industry Position

Table 29. Viatris Company Profile and Main Business

Table 30. Viatris Generic Anti-cancer Injectables Models, Specifications, and Application

Table 31. Viatris Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Viatris Recent Developments

Table 33. Biocon Company Information, Head Office, Market Area, and Industry Position

Table 34. Biocon Company Profile and Main Business

Table 35. Biocon Generic Anti-cancer Injectables Models, Specifications, and Application

Table 36. Biocon Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Biocon Recent Developments

Table 38. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 39. Amgen Company Profile and Main Business

Table 40. Amgen Generic Anti-cancer Injectables Models, Specifications, and Application

Table 41. Amgen Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Amgen Recent Developments

Table 43. Sandoz (Novartis) Company Information, Head Office, Market Area, and Industry Position

Table 44. Sandoz (Novartis) Company Profile and Main Business

Table 45. Sandoz (Novartis) Generic Anti-cancer Injectables Models, Specifications, and Application

Table 46. Sandoz (Novartis) Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Sandoz (Novartis) Recent Developments

Table 48. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 49. Pfizer Company Profile and Main Business

Table 50. Pfizer Generic Anti-cancer Injectables Models, Specifications, and Application

Table 51. Pfizer Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Pfizer Recent Developments

Table 53. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 54. Qilu Pharmaceutical Company Profile and Main Business

Table 55. Qilu Pharmaceutical Generic Anti-cancer Injectables Models, Specifications, and Application

Table 56. Qilu Pharmaceutical Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Qilu Pharmaceutical Recent Developments

Table 58. Jiangsu Hansoh Company Information, Head Office, Market Area, and Industry Position

Table 59. Jiangsu Hansoh Company Profile and Main Business

Table 60. Jiangsu Hansoh Generic Anti-cancer Injectables Models, Specifications, and Application

Table 61. Jiangsu Hansoh Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Jiangsu Hansoh Recent Developments

Table 63. CTTQ Company Information, Head Office, Market Area, and Industry Position

Table 64. CTTQ Company Profile and Main Business

Table 65. CTTQ Generic Anti-cancer Injectables Models, Specifications, and Application

Table 66. CTTQ Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. CTTQ Recent Developments

Table 68. Jiangsu Hengrui Company Information, Head Office, Market Area, and Industry Position

Table 69. Jiangsu Hengrui Company Profile and Main Business

Table 70. Jiangsu Hengrui Generic Anti-cancer Injectables Models, Specifications, and Application

Table 71. Jiangsu Hengrui Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Jiangsu Hengrui Recent Developments

Table 73. CSPC Company Information, Head Office, Market Area, and Industry Position

Table 74. CSPC Company Profile and Main Business

Table 75. CSPC Generic Anti-cancer Injectables Models, Specifications, and Application

Table 76. CSPC Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 77. CSPC Recent Developments

Table 78. Innovent Biologics Company Information, Head Office, Market Area, and Industry Position

Table 79. Innovent Biologics Company Profile and Main Business

Table 80. Innovent Biologics Generic Anti-cancer Injectables Models, Specifications, and Application

Table 81. Innovent Biologics Generic Anti-cancer Injectables Revenue and Gross Margin, US$ Million, 2020-2025

Table 82. Innovent Biologics Recent Developments

List of Figures

Figure 1. Generic Anti-cancer Injectables Picture

Figure 2. Global Generic Anti-cancer Injectables Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Generic Anti-cancer Injectables Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Generic Anti-cancer Injectables Market Share of Global, 2020-2031

Figure 5. Global Generic Anti-cancer Injectables Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Generic Anti-cancer Injectables Key Participants, Market Share, 2024

Figure 7. Generic Anti-cancer Injectables Industry Chain

Figure 8. Generic Anti-cancer Injectables Procurement Model

Figure 9. Generic Anti-cancer Injectables Sales Model

Figure 10. Generic Anti-cancer Injectables Sales Channels, Direct Sales, and Distribution

Figure 11. Bevacizuma

Figure 12. Rituximab

Figure 13. Herceptin

Figure 14. Paclitaxel

Figure 15. Others

Figure 16. by Type, Global Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 17. by Type, Global Generic Anti-cancer Injectables Consumption Value Market Share, 2020-2031

Figure 18. Hospital

Figure 19. Retail

Figure 20. by Application, Global Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 21. by Application, Global Generic Anti-cancer Injectables Revenue Market Share, 2020-2031

Figure 22. By Region, Global Generic Anti-cancer Injectables Consumption Value Market Share, 2020-2031

Figure 23. North America Generic Anti-cancer Injectables Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 24. By Country, North America Generic Anti-cancer Injectables Consumption Value Market Share, 2024

Figure 25. Europe Generic Anti-cancer Injectables Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 26. By Country, Europe Generic Anti-cancer Injectables Consumption Value Market Share, 2024

Figure 27. Asia Pacific Generic Anti-cancer Injectables Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 28. By Country/Region, Asia Pacific Generic Anti-cancer Injectables Consumption Value Market Share, 2024

Figure 29. South America Generic Anti-cancer Injectables Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 30. By Country, South America Generic Anti-cancer Injectables Consumption Value Market Share, 2024

Figure 31. Middle East & Africa Generic Anti-cancer Injectables Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 32. United States Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 33. by Type, United States Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 34. by Application, United States Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 35. Europe Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 36. by Type, Europe Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 37. by Application, Europe Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 38. China Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 39. by Type, China Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 40. by Application, China Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 41. Japan Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 42. by Type, Japan Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 43. by Application, Japan Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 44. South Korea Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 45. by Type, South Korea Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 46. by Application, South Korea Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 47. Southeast Asia Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 48. by Type, Southeast Asia Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 49. by Application, Southeast Asia Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 50. India Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 51. by Type, India Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 52. by Application, India Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 53. Middle East & Africa Generic Anti-cancer Injectables Consumption Value, 2020-2031, US$ Million

Figure 54. by Type, Middle East & Africa Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 55. by Application, Middle East & Africa Generic Anti-cancer Injectables Consumption Value Market Share, 2024 VS 2031

Figure 56. Research Methodology

Figure 57. Breakdown of Primary Interviews

Figure 58. Bottom-up Approaches

Figure 59. Top-down Approaches